Edition:
United States

Kaken Pharmaceutical Co Ltd (4521.T)

4521.T on Tokyo Stock Exchange

6,550JPY
2:00am EDT
Change (% chg)

¥100 (+1.55%)
Prev Close
¥6,450
Open
¥6,460
Day's High
¥6,570
Day's Low
¥6,430
Volume
141,700
Avg. Vol
195,327
52-wk High
¥7,280
52-wk Low
¥5,410

Latest Key Developments (Source: Significant Developments)

Kaken Pharmaceutical gets domestic manufacture and marketing approval for periodontium regeneration medicine
Wednesday, 28 Sep 2016 03:26am EDT 

Kaken Pharmaceutical Co Ltd <4521.T>:Says it received domestic manufacture and marketing approval for a periodontium regeneration medicine.  Full Article

Kaken Pharmaceutical to co-promote allergic medicine with Kyorin Holdings unit
Monday, 11 Jul 2016 02:00am EDT 

Kaken Pharmaceutical Co Ltd <4521.T>:Says the company entered into basic agreement with Kyorin Holdings Inc <4569.T>'s unit on co-promotion of an allergic medicine, whose exclusive sales right is owned by the Kyorin Holdings's unit.  Full Article

Kaken Pharmaceutical appoints ARK MEIJI AUDIT & Co. as auditor
Thursday, 30 Jun 2016 10:09pm EDT 

Kaken Pharmaceutical Co Ltd <4521.T>:Says it appointed ARK MEIJI AUDIT & Co. as auditor, effective July 1.  Full Article

Kaken Pharmaceutical signs agreement with Dong-A ST for Clenafin/Jublia in Korea
Monday, 30 May 2016 11:03pm EDT 

Kaken Pharmaceutical Co Ltd <4521.T> : Says Kaken Pharmaceutical <4521.T> and A Korea-based firm Dong-A ST Co Ltd <170900.KS> concluded an exclusive distribution agreement for the topical formulation for Onychomycosis “Clenafin / Jublia” in Korea .Says according to the agreement, Kaken hereby grant to Dong-A the exclusive right for development and sales of the Product in Korea.  Full Article

KAKEN PHARMACEUTICAL signs exclusive licensing contract
Tuesday, 26 Apr 2016 03:30am EDT 

KAKEN PHARMACEUTICAL CO LTD:Signed a licensing contract with MediWound Ltd., and MediWound Ltd. to granted the company exclusive development and sale rights in Japan for burn eschar remover (NexoBrid®).  Full Article

KAKEN PHARMACEUTICAL to merge with subsidiary
Tuesday, 27 Oct 2015 03:00am EDT 

KAKEN PHARMACEUTICAL CO LTD:To merge with its Tokyo-based wholly owned subsidiary on March 31, 2016.Says the subsidiary to be dissolved after the transaction.  Full Article

KAKEN PHARMACEUTICAL raises consolidated mid-year and full-year outlook and dividend forecast for FY 2016
Tuesday, 27 Oct 2015 03:00am EDT 

KAKEN PHARMACEUTICAL CO LTD:Says the company increased the consolidated mid-year outlook for revenue to 55,000 mln yen from 48,800 mln yen, for the fiscal year ending March 2016.Operating profit forecast increased to 18,400 mln yen from 10,500 mln yen.Ordinary profit forecast increased to 18,600 mln yen from 10,600 mln yen.Net profit forecast increased to 12,500 mln yen from 7,100 mln yen.Earnings per share increased to 301.86 yen from 171.46 yen.Says the company increased the consolidated full-year outlook for revenue to 107,900 mln yen from 98,500 mln yen, for the fiscal year ending March 2016.Operating profit forecast increased to 32,200 mln yen from 21,000 mln yen.Ordinary profit forecast increased to 32,400 mln yen from mln yen.Net profit forecast increased to 19,200 mln yen from 14,000 mln yen.Earnings per share increased to 463.66 yen from 338.09 yen.Says it raised the year-end dividend forecast to 78 yen per share from 68 yen per share for the fiscal year ending March 2016.  Full Article

KAKEN PHARMACEUTICAL announces rating withdrawal by R&I
Monday, 27 Jul 2015 02:00am EDT 

KAKEN PHARMACEUTICAL CO LTD:Says R&I's withdrew the rating on the company of "A-".  Full Article

KAKEN PHARMACEUTICAL raises year-end dividend forecast for FY 2015
Wednesday, 27 May 2015 03:00am EDT 

KAKEN PHARMACEUTICAL CO LTD:Raised year-end dividend forecast to 68 yen per share from 34 yen per share for FY ended March 2015.  Full Article

KAKEN PHARMACEUTICAL to issue year-end dividend for FY 2015
Tuesday, 12 May 2015 12:30am EDT 

KAKEN PHARMACEUTICAL CO LTD:To issue a year-end dividend of 32 yen per share to all the shareholders of record as of March 31, for FY ended March 2015.Payment date June 29.Says latest dividend forecast was 31 yen per share.  Full Article

More From Around the Web